To demonstrate the in situ efficiency of BIND&MODIFY, we explored the H3K27me3/CTCF status in the breast cancer cell lines MCF-7 and 4T1 using BIND&MODIFY and cross-validated it with ChIP-seq. Here, CTCF is linked to breast carcinoma.